References
- Karakelides M., Monson K. L., Volcheck G. W., Weiler C. R. Monoclonal gammopathies and malignancies in patients with chronic urticaria. Int J Dermatol 2006; 45: 1032–8
- Yell J. A., Mbuagbaw J., Burge S. M. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 1996; 135: 355–62
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
- Fries J. F., Holman H. R. Systemic lupus erythematosus: a clinical analysis. Major Probl Intern Med 1975; 6: v–199
- Lee P., Urowitz M. B., Bookman A. A., Koehler B. E., Smythe H. A., Gordon D. A., et al. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 1977; 46: 1–32
- Wechalekar A., Cranfield T., Sinclair D., Ganzckowski M. Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation. Clin Lab Haematol 2005; 27: 247–9
- Wisnieski J. J. Urticarial vasculitis. Curr Opin Rheumatol 2000; 12: 24–31
- Bjornadal L., Lofstrom B., Yin L., Lundberg I. E., Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 66–71
- Taguchi F., Miyoshi T., Nakajima N., Nishimura J., Nawata H. Acute promyelocytic leukemia developed in the course of systemic lupus erythematosus: a case report [in Japanese]. Rinsho Ketsueki 1990; 31: 1965–6
- Strom S. S., Gu Y., Gruschkus S. K., Pierce S. A., Estey E. H. Risk factors of myelodysplastic syndromes: a case–control study. Leukemia 2005; 19: 1912–18
- Ng H. S., Ng H. W., Sinniah R., Feng P. H. A case of systemic lupus erythematosus with sideroblastic anaemia terminating in erythroleukaemia. Ann Rheum Dis 1981; 40: 422–6
- Ando M., Narabayashi M., Watanabe T., Kamiya Y., Togitani K., Tanosaki R., et al. Therapy‐related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines. Jpn J Clin Oncol 1999; 29: 28–32
- West W. O. Acute erythroid leukemia after cyclophosphamide therapy for multiple myeloma: report of two cases. South Med J 1976; 69: 1331–2
- Takaoka T., Matsukawa Y., Tomita Y., Kitamura N., Yamazaki T., Takeuchi J., et al. Development of erythroleukaemia after myelodysplastic syndrome in a patient with Wegener's granulomatosis. Ann Rheum Dis 2001; 60: 899–900
- Devereux S. Therapy associated leukaemia. Blood Rev 1991; 5: 138–45